Prognosis following acute myocardial infarction: Insights from cardiovascular magnetic resonance

Current Cardiology Reports

Volumn 9, Issue 1, 2007, Pages 57-62

  Duffy, Kevin J ^a   Ferrari, Victor A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; GADOLINIUM CHELATE;

ACUTE HEART INFARCTION; CAPILLARY FLOW; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; HEART CONTRACTION; HEART INFARCTION SIZE; HUMAN; INTERMETHOD COMPARISON; LOW DRUG DOSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERFUSION WEIGHTED IMAGING; PREDICTION; PROGNOSIS; REVASCULARIZATION; REVIEW; SENSITIVITY AND SPECIFICITY;

ANIMALS; CORONARY CIRCULATION; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 34047274069     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-007-0011-z     Document Type: Review

References (39)

1. Baer FM, Theissen P, Schneider CA, et al.: Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998, 31:1040-1048.
2. Baer FM, Voth E, LaRosee K, et al.: Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. Am J Cardiol 1996, 78:415-419.
3. Baer FM, Voth E, Schneider CA, et al.: Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 1995, 91:1006-1015.
4. Dendale P, Franken PR, Holman E, et al.: Validation of low-dose dobutamine magnetic resonance imaging for assessment of myocardial viability after infarction by serial imaging. Am J Cardiol 1998, 82:375-377.
5. Uemura S, Sakuma H, Motoyasu M, et al.: Thallium-201 SPECT and low-dose dobutamine stress cine MRI for predicting functional recovery of regional myocardial contraction in patients with myocardial infarction. J Cardiovasc Magn Reson 2004, 6:697-707.
6. Croisille P, Moore CC, Judd RM, et al.: Differentiation of viable and nonviable myocardium by the use of three-dimensional tagged MRI in 2-day-old reperfused canine infarcts. Circulation 1999, 99:284-291.
7. Sayad DE, Willett DL, Hundley WG, et al.: Dobutamine magnetic resonance imaging with myocardial tagging quantitatively predicts improvement in regional function after revascularization. Am J Cardiol 1998, 82:1149-1151.
8. Axel L, Dougherty L: Heart wall motion: improved method of spatial modulation of magnetization for MR imaging. Radiology 1989, 172:349-350.
9. Young AA, Imai H, Chang CN, Axel L: Two-dimensional left ventricular deformation during systole using magnetic resonance imaging with spatial modulation of magnetization. [Erratum appears in Circulation 1994, 90:1584]. Circulation 1994, 89:740-752.
10. Geskin G, Kramer CM, Rogers WJ, et al.: Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation 1998, 98:217-223.
11. Kramer CM, Malkowski MJ, Mankad S, et al.: Magnetic resonance tagging and echocardiographic response to dobutamine and functional improvement after reperfused myocardial infarction. Am Heart J 2002, 143:1046-1051.
12. Selvanayagam JB, Jerosch-Herold M, Porto I, et al.: Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment [see comment]. Circulation 2005, 112:3289-3296.
13. Amado LC, Gerber BL, Gupta SN, et al.: Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 2004, 44:2383-2389.
14. Kim RJ, Fieno DS, Parrish TB, et al.: Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100:1992-2002.
15. Wagner A, Mahrholdt H, Holly TA, et al.: Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study [see comment]. Lancet 2003, 361:374-379.
16. Rogers WJ, Jr., Kramer CM, Geskin G, et al.: Early contrast-enhanccd MRI predicts late functional recovery after reperfused myocardial infarction. Circulation 1999, 99:744-750.
17. Kim RJ, Wu E, Rafael A, et al.: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction [see comment]. N Engl J Med 2000, 343:1445-1453.
18. Beek AM, Kuhl HP, Bondarenko O, et al.: Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction [see comment]. J Am Coll Cardiol 2003, 42:895-901.
19. Choi KM, Kim RJ, Gubernikoff G, et al.: Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001, 104:1101-1107.
20. Selvanayagam JB, Kardos A, Francis JM, et al.: Value of delayed-enhanccment cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization [see comment]. Circulation 2004, 110:1535-1541.
21. Ichikawa Y, Sakuma H, Suzawa N, et al.: Late gadolinium-enhanced magnetic resonance imaging in acute and chronic myocardial infarction. Improved prediction of regional myocardial contraction in the chronic state by measuring thickness of nonenhanced myocardium. J Am Coll Cardiol 2005, 45:901-909.
22. Gerber BL, Garot J, Bluemke DA, et al.: Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002, 106:1083-1089.
23. Kwong RY, Chan AK, Brown KA, et al.: Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease [see comment]. Circulation 2006, 113:2733-2743.
24. Baks T, van Geuns R-J, Biagini E, et al.: Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics. J Am Coll Cardiol 2006, 47:40-44.
25. Hombach V, Grebe O, Merkle N, et al.: Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging [see comment]. Eur Heart J 2005, 26:549-557.
26. Ingkanisorn WP, Rhoads KL, Aletras AH, et al.: Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004, 43:22S3-2259.
27. Choi CJ, Haji-Momenian S, Dimaria JM, et al.: Infarct involution and improved function during healing of acute myocardial infarction: the role of microvascular obstruction. J Cardiovasc Magn Reson 2004, 6:917-925.
28. Motoyasu M, Sakuma H, Ichikawa Y, et al.: Prediction of regional functional recovery after acute myocardial infarction with low dose dobutamine stress cine MR imaging and contrast enhanced MR imaging. J Cardiovasc Magn Reson 2003, 5:563-574.
29. Wellnhofer E, Olariu A, Klein C, et al.: Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery [see comment]. Circulation 2004, 109:2172-2174.
30. Wu KC, Zerhouni EA, Judd RM, et al.: Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998, 97:765-772.
31. Wu KC, Kim RJ, Bluemke DA, et al.: Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol 1998, 32:1756-1764.
32. Janardhanan R, Moon JCC, Pennell DJ, Senior R: Myocardial contrast echocardiography accurately reflects transmurality of myocardial necrosis and predicts contractile reserve after acute myocardial infarction. Am Heart J 2005, 149:355-362.
33. Biagini E, van Geuns RJ, Baks T, et al.: Comparison between contrast echocardiography and magnetic resonance imaging to predict improvement of myocardial function after primary coronary intervention. Am J Cardiol 2006, 97:361-366.
34. Gerber BL, Rochitte CE, Melin JA, et al.: Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 2000, 101:2734-2741.
35. Gerber BL, Rochitte CE, Bluemke DA, et al.: Relation between Gd-DTPA contrast enhancement and regional inotropic response in the periphery and center of myocardial infarction. Circulation 2001, 104:998-1004.
36. Taylor AJ, Al-Saadi N, Abdel-Aty H, et al.: Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation 2004, 109:2080-2085.
37. Bodi V, Sanchis J, Lopez-Lereu MP, et al.: Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. J Am Coll Cardiol 2005, 46:1747-1752.
38. Klem I, Heitner JF, Shah DJ, et al.: Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging [see comment]. J Am Coll Cardiol 2006, 47:1630-1638.
39. Yan AT, Shayne AJ, Brown KA, et al.: Characterization of the peri-infarct zone by contrast-enhanccd cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006, 114:32-39.